Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

A review of rate control in atrial fibrillation, and the rationale and protocol for the RATE-AF trial.

Kotecha D, Calvert M, Deeks JJ, Griffith M, Kirchhof P, Lip GY, Mehta S, Slinn G, Stanbury M, Steeds RP, Townend JN.

BMJ Open. 2017 Jul 20;7(7):e015099. doi: 10.1136/bmjopen-2016-015099.

2.

A comparison of predictors and intensity of acute postsurgical pain in patients undergoing total hip and knee arthroplasty.

Pinto PR, McIntyre T, Araújo-Soares V, Costa P, Ferrero R, Almeida A.

J Pain Res. 2017 May 9;10:1087-1098. doi: 10.2147/JPR.S126467. eCollection 2017.

3.

Photodynamic therapy and imaging based on tumor-targeted nanoprobe, polymer-conjugated zinc protoporphyrin.

Fang J, Liao L, Yin H, Nakamura H, Subr V, Ulbrich K, Maeda H.

Future Sci OA. 2015 Nov 1;1(3):FSO4. doi: 10.4155/fso.15.2. eCollection 2015 Nov.

4.

Transpupillary Argon Laser Cyclophotocoagulation in a Refractory Traumatic Glaucoma Patient with Aphakia and Aniridia.

Uzunel UD, Yüce B, Küsbeci T, Ateş H.

Turk J Ophthalmol. 2016 Jan;46(1):38-40. Epub 2016 Jan 5.

5.

Canaliculitis Awareness.

Balıkoğlu Yılmaz M, Şen E, Evren E, Elgin U, Yılmazbaş P.

Turk J Ophthalmol. 2016 Jan;46(1):25-29. Epub 2016 Jan 5.

6.

Comparison of Different Types of Complications in the Phacoemulsification Surgery Learning Curve According to Number of Operations Performed.

Mangan MS, Atalay E, Arıcı C, Tuncer İ, Bilgeç MD.

Turk J Ophthalmol. 2016 Jan;46(1):7-10. Epub 2016 Jan 5.

7.

Bilateral Vision Loss after Delivery in Two Cases: Severe Preeclampsia and HELLP Syndrome.

Çelik G, Eser A, Günay M, Yenerel NM.

Turk J Ophthalmol. 2015 Dec;45(6):271-273. Epub 2015 Dec 5.

8.

Evaluation of a pharmacogenetic educational toolkit for community pharmacists.

Haga SB, Mills R, Moaddeb J.

Pharmacogenomics. 2016 Sep;17(14):1491-502. doi: 10.2217/pgs-2016-0002. Epub 2016 Aug 17.

9.

Proliferation of gynaecological scientific societies and their financial transparency: an Italian survey.

Vercellini P, Viganò P, Frattaruolo MP, Somigliana E.

BMJ Open. 2016 Jan 13;6(1):e008370. doi: 10.1136/bmjopen-2015-008370.

10.

Reactive oxygen species-activated nanomaterials as theranostic agents.

Kim KS, Lee D, Song CG, Kang PM.

Nanomedicine (Lond). 2015;10(17):2709-23. doi: 10.2217/nnm.15.108. Epub 2015 Sep 2. Review.

11.

Gender Differences in Physicians' Financial Ties to Industry: A Study of National Disclosure Data.

Rose SL, Sanghani RM, Schmidt C, Karafa MT, Kodish E, Chisolm GM.

PLoS One. 2015 Jun 11;10(6):e0129197. doi: 10.1371/journal.pone.0129197. eCollection 2015.

12.

Redox nanoparticles as a novel treatment approach for inflammation and fibrosis associated with nonalcoholic steatohepatitis.

Eguchi A, Yoshitomi T, Lazic M, Johnson CD, Vong LB, Wree A, Povero D, Papouchado BG, Nagasaki Y, Feldstein AE.

Nanomedicine (Lond). 2015;10(17):2697-708. doi: 10.2217/nnm.15.87. Epub 2015 May 28.

13.

Too few, too weak: conflict of interest policies at Canadian medical schools.

Shnier A, Lexchin J, Mintzes B, Jutel A, Holloway K.

PLoS One. 2013 Jul 4;8(7):e68633. doi: 10.1371/journal.pone.0068633. Print 2013.

14.
15.

Disclosure: only a first step.

Abi-Jaoude E, Gorman DA.

CMAJ. 2010 Oct 5;182(14):1546. doi: 10.1503/cmaj.110-2109. No abstract available.

16.

Obesity, the endocannabinoid system, and bias arising from pharmaceutical sponsorship.

McPartland JM.

PLoS One. 2009;4(3):e5092. doi: 10.1371/journal.pone.0005092. Epub 2009 Mar 31.

17.
18.

Supplemental Content

Loading ...
Support Center